Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Current Assets (2016 - 2025)

Historic Current Assets for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $118.5 million.

  • Fortress Biotech's Current Assets rose 3735.02% to $118.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.5 million, marking a year-over-year increase of 3735.02%. This contributed to the annual value of $90.4 million for FY2024, which is 2277.44% down from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Current Assets is $118.5 million, which was up 3735.02% from $110.4 million recorded in Q2 2025.
  • Fortress Biotech's 5-year Current Assets high stood at $346.5 million for Q4 2021, and its period low was $86.3 million during Q3 2024.
  • For the 5-year period, Fortress Biotech's Current Assets averaged around $195.4 million, with its median value being $127.6 million (2023).
  • As far as peak fluctuations go, Fortress Biotech's Current Assets skyrocketed by 10024.62% in 2021, and later crashed by 6208.21% in 2023.
  • Over the past 5 years, Fortress Biotech's Current Assets (Quarter) stood at $346.5 million in 2021, then crashed by 33.49% to $230.4 million in 2022, then plummeted by 49.22% to $117.0 million in 2023, then decreased by 22.77% to $90.4 million in 2024, then skyrocketed by 31.13% to $118.5 million in 2025.
  • Its last three reported values are $118.5 million in Q3 2025, $110.4 million for Q2 2025, and $126.9 million during Q1 2025.